LifeStance Health Group, Inc. (LFST)
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Last price
- $12.32
- As of
Kresmion compiles this page from LFST's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
LifeStance Health Group, Inc. (LFST): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-11.
See the full LFST dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for LFST on one page. Preview it with sample data, then open it live with a free account.
Preview the LFST dossierActive signals for LFST
- highCONSENSUS_BUY
4 tracked funds increased LFST this 2026Q2, institutional consensus
- highinsider_cluster_sell
5 insiders at LFST sold $151.9M this week
- highCONSENSUS_BUY
3 tracked funds increased LFST this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +96% to LFST (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +128% to LFST (2026Q2)
FREE, NO ACCOUNT
Every signal on LFST, as it fires
You are seeing 5 of 13 signals recorded on LFST since 2026-06-19.
The five above landed across 2 days. The other 8 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in LFST (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 53228F101 · 2026Q2 | $38.6M | 0.01% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 53228F101 · 2026Q2 | $10.3M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 53228F101 · 2026Q2 | $5.9M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 53228F101 · 2026Q2 | $5.5M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 53228F101 · 2026Q2 | $1.7M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 53228F101 · 2026Q2 | $703K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, LFST
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
LFST against its peers
LFST's operating margin of 1.7% ranks in the 44th percentile of 16 Medical Care Facilities sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | LFST | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.4B USD | 1.4B USD | 53 | 17 |
| Gross margin | n/a | 23.0% | n/a | 5 |
| Operating margin | 1.7% | 3.7% | 44 | 16 |
| Net margin | 0.7% | 2.8% | 39 | 18 |
| Return on equity | 0.6% | 8.8% | 34 | 15 |
| P / E | 616.0x | 22.3x | 95 | 9 |
| 1 year | 141.1% | 14.5% | 90 | 14 |
Peers (18): CON, NHC, GRDN, ADUS, FMS, ASTH, SGRY, SNDA, ARDT, AGL, NUTX, INNV, TOI, MCTA, CYH, SRTA, AIRS, JYNT. Left out: BUHPY (no annual filing), LTGHY (no annual filing), FSNUY (no annual filing), GMRS (no annual filing), AUNA (no annual filing), HWAIF (no annual filing), WW (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (LFST: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow LFST on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to LFST for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.